dsip for humans DSIP | Peptra Labs -

N-terminal hexanoyl and C-terminal modifications create more stable, lipophilic molecule

Accordingly, efforts to lower cholesterol to mitigate cardiovascular risk should be paired with measures to reduce other risk factors such as inflammation, oxidation, hypertension, excess plasma glucose, excess body weight, excess fibrinogen, excess homocysteine, low vitamin K, insufficient vitamin D, hormone imbalance, etc

Wang, D., Chai, X

Peptides referenced are for research use

This separation explains why combining cagrilintide with semaglutide in the CagriSema combination produces additive weight loss exceeding either medication alone